FromAstraZeneca ([email protected])
Subject (122)Enhertu showed substantial clinical activity in patients with HER2-positive metastatic breast cancer and brain metastases
Preheader (121)Enhertu showed substantial clinical activity in patients with HER2-positive metastatic breast cancer and brain metastases
Arial
Text Analysis
Body Words193
Subject Words15
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px716 px
X-Spam Score-0.2
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEvening
